APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Seasonal Affective Disorder Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Seasonal Affective Disorder Drugs Industry Growth and Trends Forecast to 2032

Report ID 174034340122 December 202595 pages

Choose your research edition.

Industry ResearchSeasonal Affective Disorder Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasonal Affective Disorder Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Seasonal Affective Disorder Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasonal Affective Disorder Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasonal Affective Disorder Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Seasonal Affective Disorder Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Seasonal Affective Disorder Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Seasonal Affective Disorder Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Seasonal Affective Disorder Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Seasonal Affective Disorder Drugs include Merck, Mylan, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb and Otsuka Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Seasonal Affective Disorder Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Seasonal Affective Disorder Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Seasonal Affective Disorder Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Seasonal Affective Disorder Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Seasonal Affective Disorder Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Seasonal Affective Disorder Drugs Market by Company

Merck

Mylan

Pfizer

GlaxoSmithKline

Bristol-Myers Squibb

Otsuka Pharmaceutical

Seasonal Affective Disorder Drugs Segment by Type

TCAs

SSRIs

SNRIs

NDRIs

MOAIs

Seasonal Affective Disorder Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Seasonal Affective Disorder Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Affective Disorder Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasonal Affective Disorder Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Affective Disorder Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Seasonal Affective Disorder Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Seasonal Affective Disorder Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of TCAs Table 2. Major Company of SSRIs Table 3. Major Company of SNRIs Table 4. Major Company of NDRIs Table 5. Major Company of MOAIs Table 6. Global Seasonal Affective Disorder Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (k units) Table 8. Global Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Seasonal Affective Disorder Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Seasonal Affective Disorder Drugs Price by Type (2021-2026) & (US$/unit) Table 12. Global Seasonal Affective Disorder Drugs Sales by Type (2027-2032) & (k units) Table 13. Global Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Seasonal Affective Disorder Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Seasonal Affective Disorder Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Seasonal Affective Disorder Drugs Price by Type (2027-2032) & (US$/unit) Table 17. North America Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (k units) Table 18. North America Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (k units) Table 20. Europe Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (k units) Table 24. Latin America Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Seasonal Affective Disorder Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Seasonal Affective Disorder Drugs Industry Trends Table 28. Seasonal Affective Disorder Drugs Industry Drivers Table 29. Seasonal Affective Disorder Drugs Industry Opportunities and Challenges Table 30. Seasonal Affective Disorder Drugs Industry Restraints Table 31. Global Seasonal Affective Disorder Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Seasonal Affective Disorder Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Seasonal Affective Disorder Drugs Sales by Company (2021-2026) & (k units) Table 34. Global Seasonal Affective Disorder Drugs Sales Share by Company (2021-2026) Table 35. Global Seasonal Affective Disorder Drugs Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Seasonal Affective Disorder Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Seasonal Affective Disorder Drugs Major Company Production Sites and Headquarters Table 38. Global Seasonal Affective Disorder Drugs Company, Product Type & Application Table 39. Global Seasonal Affective Disorder Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Seasonal Affective Disorder Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Seasonal Affective Disorder Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Seasonal Affective Disorder Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Seasonal Affective Disorder Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Seasonal Affective Disorder Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Seasonal Affective Disorder Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Seasonal Affective Disorder Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Seasonal Affective Disorder Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Seasonal Affective Disorder Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Seasonal Affective Disorder Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Seasonal Affective Disorder Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Seasonal Affective Disorder Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Seasonal Affective Disorder Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Seasonal Affective Disorder Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Seasonal Affective Disorder Drugs Price by Application (2021-2026) & (US$/unit) Table 59. Global Seasonal Affective Disorder Drugs Sales by Application (2027-2032) & (k units) Table 60. Global Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Seasonal Affective Disorder Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Seasonal Affective Disorder Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Seasonal Affective Disorder Drugs Price by Application (2027-2032) & (US$/unit) Table 64. North America Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (k units) Table 65. North America Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (k units) Table 67. Europe Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (k units) Table 71. Latin America Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Seasonal Affective Disorder Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Seasonal Affective Disorder Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Seasonal Affective Disorder Drugs Product Portfolio Table 78. Merck Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Seasonal Affective Disorder Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Mylan Seasonal Affective Disorder Drugs Product Portfolio Table 83. Mylan Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Seasonal Affective Disorder Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Seasonal Affective Disorder Drugs Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Seasonal Affective Disorder Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Seasonal Affective Disorder Drugs Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Bristol-Myers Squibb Company Information Table 95. Bristol-Myers Squibb Business Overview Table 96. Bristol-Myers Squibb Seasonal Affective Disorder Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Bristol-Myers Squibb Seasonal Affective Disorder Drugs Product Portfolio Table 98. Bristol-Myers Squibb Recent Development Table 99. Otsuka Pharmaceutical Company Information Table 100. Otsuka Pharmaceutical Business Overview Table 101. Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Product Portfolio Table 103. Otsuka Pharmaceutical Recent Development Table 104. North America Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 105. North America Seasonal Affective Disorder Drugs Sales by Country (2021-2026) & (k units) Table 106. North America Seasonal Affective Disorder Drugs Sales Market Share by Country (2021-2026) Table 107. North America Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032) & (k units) Table 108. North America Seasonal Affective Disorder Drugs Sales Market Share Forecast by Country (2027-2032) Table 109. North America Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. North America Seasonal Affective Disorder Drugs Market Size by Country (2021-2026) & (US$ Million) Table 111. North America Seasonal Affective Disorder Drugs Market Share by Country (2021-2026) Table 112. North America Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. North America Seasonal Affective Disorder Drugs Market Share Forecast by Country (2027-2032) Table 114. Europe Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. Europe Seasonal Affective Disorder Drugs Sales by Country (2021-2026) & (k units) Table 116. Europe Seasonal Affective Disorder Drugs Sales Market Share by Country (2021-2026) Table 117. Europe Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032) & (k units) Table 118. Europe Seasonal Affective Disorder Drugs Sales Market Share Forecast by Country (2027-2032) Table 119. Europe Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Europe Seasonal Affective Disorder Drugs Market Size by Country (2021-2026) & (US$ Million) Table 121. Europe Seasonal Affective Disorder Drugs Market Share by Country (2021-2026) Table 122. Europe Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Europe Seasonal Affective Disorder Drugs Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Country (2021-2026) & (k units) Table 126. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share by Country (2021-2026) Table 127. Asia-Pacific Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032) & (k units) Table 128. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Seasonal Affective Disorder Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. Asia-Pacific Seasonal Affective Disorder Drugs Market Share by Country (2021-2026) Table 132. Asia-Pacific Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Asia-Pacific Seasonal Affective Disorder Drugs Market Share Forecast by Country (2027-2032) Table 134. Latin America Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Latin America Seasonal Affective Disorder Drugs Sales by Country (2021-2026) & (k units) Table 136. Latin America Seasonal Affective Disorder Drugs Sales Market Share by Country (2021-2026) Table 137. Latin America Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032) & (k units) Table 138. Latin America Seasonal Affective Disorder Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Latin America Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Latin America Seasonal Affective Disorder Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Latin America Seasonal Affective Disorder Drugs Market Share by Country (2021-2026) Table 142. Latin America Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Latin America Seasonal Affective Disorder Drugs Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Seasonal Affective Disorder Drugs Sales by Country (2021-2026) & (k units) Table 146. Middle East and Africa Seasonal Affective Disorder Drugs Sales Market Share by Country (2021-2026) Table 147. Middle East and Africa Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032) & (k units) Table 148. Middle East and Africa Seasonal Affective Disorder Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Seasonal Affective Disorder Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Seasonal Affective Disorder Drugs Market Share by Country (2021-2026) Table 152. Middle East and Africa Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Middle East and Africa Seasonal Affective Disorder Drugs Market Share Forecast by Country (2027-2032) Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Seasonal Affective Disorder Drugs Distributors List Table 157. Seasonal Affective Disorder Drugs Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Seasonal Affective Disorder Drugs Image Figure 2. Global Seasonal Affective Disorder Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Seasonal Affective Disorder Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Seasonal Affective Disorder Drugs Sales (2021-2032) & (k units) Figure 5. TCAs Image Figure 6. Global TCAs Sales YoY Growth (2021-2032) & (k units) Figure 7. SSRIs Image Figure 8. Global SSRIs Sales YoY Growth (2021-2032) & (k units) Figure 9. SNRIs Image Figure 10. Global SNRIs Sales YoY Growth (2021-2032) & (k units) Figure 11. NDRIs Image Figure 12. Global NDRIs Sales YoY Growth (2021-2032) & (k units) Figure 13. MOAIs Image Figure 14. Global MOAIs Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Seasonal Affective Disorder Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Seasonal Affective Disorder Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Seasonal Affective Disorder Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Seasonal Affective Disorder Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Seasonal Affective Disorder Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Seasonal Affective Disorder Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Seasonal Affective Disorder Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Seasonal Affective Disorder Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Pharmacies Image Figure 32. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Seasonal Affective Disorder Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Seasonal Affective Disorder Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Seasonal Affective Disorder Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Seasonal Affective Disorder Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Seasonal Affective Disorder Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Seasonal Affective Disorder Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Seasonal Affective Disorder Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Seasonal Affective Disorder Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Seasonal Affective Disorder Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Seasonal Affective Disorder Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Seasonal Affective Disorder Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Seasonal Affective Disorder Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Seasonal Affective Disorder Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Seasonal Affective Disorder Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Seasonal Affective Disorder Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Seasonal Affective Disorder Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Seasonal Affective Disorder Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Seasonal Affective Disorder Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Seasonal Affective Disorder Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Seasonal Affective Disorder Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Seasonal Affective Disorder Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Seasonal Affective Disorder Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Seasonal Affective Disorder Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Seasonal Affective Disorder Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Seasonal Affective Disorder Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Seasonal Affective Disorder Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Seasonal Affective Disorder Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Seasonal Affective Disorder Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • TCAs
  • SSRIs
  • SNRIs
  • NDRIs
  • MOAIs
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Merck
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • Otsuka Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Seasonal Affective Disorder Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Seasonal Affective Disorder Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Seasonal Affective Disorder Drugs Market by Type
  6. 1.3.1 TCAs
  7. 1.3.2 SSRIs
  8. 1.3.3 SNRIs
  9. 1.3.4 NDRIs
  10. 1.3.5 MOAIs
  11. 1.4 Global Seasonal Affective Disorder Drugs Market Size by Type
  12. 1.4.1 Global Seasonal Affective Disorder Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Seasonal Affective Disorder Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Seasonal Affective Disorder Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Seasonal Affective Disorder Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Seasonal Affective Disorder Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Seasonal Affective Disorder Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Seasonal Affective Disorder Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Seasonal Affective Disorder Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Seasonal Affective Disorder Drugs Industry Trends
  2. 2.2 Seasonal Affective Disorder Drugs Industry Drivers
  3. 2.3 Seasonal Affective Disorder Drugs Industry Opportunities and Challenges
  4. 2.4 Seasonal Affective Disorder Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Seasonal Affective Disorder Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Seasonal Affective Disorder Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Seasonal Affective Disorder Drugs Price (2021-2026)
  4. 3.4 Global Seasonal Affective Disorder Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Seasonal Affective Disorder Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Seasonal Affective Disorder Drugs Company, Product Type & Application
  7. 3.7 Global Seasonal Affective Disorder Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Seasonal Affective Disorder Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Seasonal Affective Disorder Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Seasonal Affective Disorder Drugs Tier 1, Tier 2, and Tier 3
4 Seasonal Affective Disorder Drugs Regional Status and Outlook
  1. 4.1 Global Seasonal Affective Disorder Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Seasonal Affective Disorder Drugs Historic Market Size by Region
  3. 4.2.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Seasonal Affective Disorder Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Seasonal Affective Disorder Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Seasonal Affective Disorder Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Seasonal Affective Disorder Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Seasonal Affective Disorder Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Seasonal Affective Disorder Drugs by Application
  1. 5.1 Seasonal Affective Disorder Drugs Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Seasonal Affective Disorder Drugs Market Size by Application
  6. 5.2.1 Global Seasonal Affective Disorder Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Seasonal Affective Disorder Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Seasonal Affective Disorder Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Seasonal Affective Disorder Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Seasonal Affective Disorder Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Seasonal Affective Disorder Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Seasonal Affective Disorder Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Seasonal Affective Disorder Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Seasonal Affective Disorder Drugs Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Seasonal Affective Disorder Drugs Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Seasonal Affective Disorder Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Seasonal Affective Disorder Drugs Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
  31. 6.6 Otsuka Pharmaceutical
  32. 6.6.1 Otsuka Pharmaceutical Company Information
  33. 6.6.2 Otsuka Pharmaceutical Business Overview
  34. 6.6.3 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Product Portfolio
  36. 6.6.5 Otsuka Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Seasonal Affective Disorder Drugs Sales by Country
  2. 7.1.1 North America Seasonal Affective Disorder Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Seasonal Affective Disorder Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Seasonal Affective Disorder Drugs Market Size by Country
  6. 7.2.1 North America Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Seasonal Affective Disorder Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Seasonal Affective Disorder Drugs Sales by Country
  2. 8.1.1 Europe Seasonal Affective Disorder Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Seasonal Affective Disorder Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Seasonal Affective Disorder Drugs Market Size by Country
  6. 8.2.1 Europe Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Seasonal Affective Disorder Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Seasonal Affective Disorder Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Seasonal Affective Disorder Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Seasonal Affective Disorder Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Seasonal Affective Disorder Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Seasonal Affective Disorder Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Seasonal Affective Disorder Drugs Sales by Country
  2. 10.1.1 South America Seasonal Affective Disorder Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Seasonal Affective Disorder Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Seasonal Affective Disorder Drugs Market Size by Country
  6. 10.2.1 South America Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Seasonal Affective Disorder Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Seasonal Affective Disorder Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Seasonal Affective Disorder Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Seasonal Affective Disorder Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Seasonal Affective Disorder Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Seasonal Affective Disorder Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Seasonal Affective Disorder Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Seasonal Affective Disorder Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Seasonal Affective Disorder Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Seasonal Affective Disorder Drugs Value Chain Analysis
  2. 12.1.1 Seasonal Affective Disorder Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Seasonal Affective Disorder Drugs Production Mode & Process
  7. 12.2 Seasonal Affective Disorder Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Seasonal Affective Disorder Drugs Distributors
  10. 12.2.3 Seasonal Affective Disorder Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst